Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Why Mallinckrodt Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket

Author: Lisa Levin | June 05, 2023 08:10am

Gainers

  • Forza X1, Inc. (NASDAQ:FRZA) shares rose 85.6% to $2.32 in pre-market trading after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!'
  • Chijet Motor Company, Inc. (NASDAQ:CJET) shares surged 60.3% to $6.14 in pre-market trading after dipping around 33% on Friday.
  • Evaxion Biotech A/S (NASDAQ:EVAX) shares gained 41.8% to $2.17 in pre-market trading after the company announced that its melanoma trial met its primary endpoints. The company said proprietary AI technology pioneer was able to identify high-quality cancer vaccine targets.
  • Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) gained 33.8% to $18.19 in pre-market trading after the company announced overall response rate of 67% and clinical benefit rate of 93% in 69 heavily pretreated RANO-HGG evaluable patients in pediatric low-grade glioma trial.
  • Golden Minerals Company (NASDAQ:AUMN) shares rose 23.6% to $0.1373 in pre-market trading. Golden Minerals Company recently announced a 1-for-25 reverse stock split.
  • Dunxin Financial Holdings Limited (NYSE:DXF) gained 19.6% to $0.2463 in pre-market trading after gaining over 15% on Friday.
  • Kaspien Holdings Inc. (NASDAQ:KSPN) shares climbed 18.1% to $0.35 in pre-market trading. Kaspien recently announced a voluntary delisting from The Nasdaq Capital Market.
  • MultiMetaVerse Holdings Limited (NASDAQ:MMV) rose 17.2% to $2.39 in pre-market trading. MultiMetaVerse shares jumped 117% on Friday after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.
  • Sentage Holdings Inc. (NASDAQ:SNTG) shares gained 17.2% to $2.80 in pre-market trading.
  • CBL International Limited (NASDAQ:BANL) rose 11.1% to $3.01 in pre-market trading. CBL International recently reported a 41.8% year-over-year revenue growth in FY22.

Losers

  • Mallinckrodt plc (NYSE:MNK) fell 20.4% to $1.95 in pre-market. Mallinckrodt is considering options including filing for bankruptcy again, according to the Wall Street Journal.
  • Yunji Inc. (NASDAQ:YJ) shares dropped 15.5% to $0.2702 in pre-market trading. Yunji shares jumped over 50% on Friday after the company reported first-quarter financial results.
  • Minerva Surgical, Inc. (NASDAQ:UTRS) shares dropped 13.9% to $0.2522 in pre-market trading after surging over 46% on Friday.
  • Marker Therapeutics, Inc. (NASDAQ:MRKR) fell 13.1% to $1.60 in pre-market trading after gaining around 10% on Friday. Marker Therapeutics recently reported pre-clinical data of its MT-601 multiTAA-specific T cell product candidate MT-601 in lymphoma cells.
  • Cyxtera Technologies, Inc. (NASDAQ:CYXT) fell 12.5% to $0.1392 in pre-market trading after the company said, pursuant to the previously disclosed Restructuring Support Agreement it reached with certain of its lenders holding over two-thirds of its outstanding term loan, the Company and certain of its subsidiaries have initiated a pre-arranged court-supervised process under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of New Jersey.
  • Kaixin Auto Holdings (NASDAQ:KXIN) fell 11.1% to $0.3110 in pre-market trading after jumping over 16% on Friday.
  • UTime Limited (NASDAQ:UTME) fell 10.4% to $1.81 in pre-market trading after gaining 4% on Friday.
  • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares fell 9.6% to $0.2205 in pre-market trading after gaining over 8% on Friday.
  • Affimed N.V. (NYSE:AFMD) fell 8.8% to $0.80in pre-market trading. Affimed reported the presentation at the ASCO Annual Meeting of safety and efficacy data from the EGFR mutant NSCLC expansion cohort of its ongoing phase 1/2 study investigating innate cell engager (ICE®) AFM24 as monotherapy.
  • SHL Telemedicine Ltd. (NASDAQ:SHLT) fell 8.6% to $11.61 in pre-market trading after gaining 10% on Friday.

 

Now Read This: Market Volatility Falls Sharply Following Jobs Report; S&P 500 Records Weekly Gain

Posted In: AFMD AUMN BANL BJDX CJET CYXT DAWN DXF EVAX FRZA KSPN KXIN MMV MNK MRKR SHLT SNTG UTME UTRS YJ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist